Jorge E Cortes


  • 74780 Citations
  • 134 h-Index
1989 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jorge E Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Leukemia, Myeloid, Chronic Phase Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Philadelphia Chromosome Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2020

Gene Frequency
Acute Myeloid Leukemia
Leukocyte Count
Leukemia, Myeloid, Chronic Phase
Pleural Effusion
bcr-abl Fusion Proteins

Treatment patterns and deep molecular response in chronic phase–chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study

Cortes, J., Huynh, L., Mendelson, E., Brandt, P., Dalal, D., DerSarkissian, M., Cortina, D., Narkhede, S. & Sheng Duh, M., Jan 2 2020, In : Leukemia and Lymphoma. 61, 1, p. 98-107 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Proportional Hazards Models
Cluster Analysis
7 Citations (Scopus)

Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs

Jain, P., Kantarjian, H., Boddu, P. C., Nogueras-González, G. M., Verstovsek, S., Garcia-Manero, G., Borthakur, G., Sasaki, K., Kadia, T. M., Sam, P., Ahaneku, H., O’Brien, S., Estrov, Z., Ravandi, F., Jabbour, E. & Cortes, J. E., Mar 26 2019, In : Blood Advances. 3, 6, p. 851-861 11 p.

Research output: Contribution to journalArticle

Open Access
Leukemia, Myeloid, Chronic Phase
Protein-Tyrosine Kinases
Confidence Intervals
Leukemia, Myelogenous, Chronic, BCR-ABL Positive